Buy, Sell, Or Hold Lyft Stock?
Behind its simple ride-hailing concept, Lyft (NASDAQ: LYFT) has faced significant financial challenges, including ...
Fortress Biotech (FBIO) Gets a Buy from Roth MKM
Roth MKM analyst Jason Wittes maintained a Buy rating on Fortress Biotech (FBIO – Research Report) yesterday and set a price target of $15.00.